Healthcare giant Johnson & Johnson (J&J) has agreed to a proposed $5.5 billion settlement to resolve approximately 76,000 lawsuits alleging that its talc-based baby powder and related products caused ovarian cancer.
If approved by the required majority of claimants, the agreement could bring an end to a legal battle that has lasted for more than a decade and become one of the largest product liability disputes in US history.
Settlement Depends on Claimant Approval
The proposed settlement is not yet final.
For the agreement to become effective, at least 95% of eligible claimants must accept the offer.
The settlement covers nearly all remaining ovarian cancer lawsuits filed against Johnson & Johnson in federal and state courts across the United States.
If the approval threshold is not met, the company could continue facing thousands of lawsuits in courts nationwide.
Why Is Johnson & Johnson Settling?
Johnson & Johnson has consistently maintained that its talc-based products are safe and do not contain asbestos.
The company also continues to deny that its baby powder causes ovarian cancer.
According to J&J, the decision to settle is intended to end years of costly litigation and allow the company to focus on its healthcare business rather than prolonged legal battles.
The company expects to pay around $3 billion in 2027, with the remaining settlement amount scheduled for 2028.
However, legal representatives for plaintiffs have indicated that the total payout could exceed $7 billion, depending on the number of claimants who ultimately participate.
What Were the Lawsuits About?
The lawsuits alleged that prolonged use of Johnson & Johnson’s talc-based baby powder and similar products led to ovarian cancer in thousands of women.
Many plaintiffs also claimed that the talc products contained asbestos, a known carcinogen linked to several forms of cancer.
Johnson & Johnson has repeatedly rejected these allegations, stating that decades of scientific research support the safety of its talc products.
The company discontinued sales of talc-based Johnson’s Baby Powder in the United States in 2020, replacing it with a cornstarch-based version.
Why Is This Settlement Significant?
The proposed agreement could resolve nearly all existing ovarian cancer lawsuits against Johnson & Johnson in a single settlement.
Unlike previous legal efforts, the settlement applies only to current claims and does not prevent future lawsuits from being filed by individuals who may bring new allegations.
The structure of the settlement is expected to allow compensation to be distributed to existing claimants more quickly than earlier proposals.
J&J’s Legal Strategy and Court Battles
Over the years, Johnson & Johnson secured several courtroom victories, including favorable verdicts in individual cases and rulings limiting certain scientific evidence presented by plaintiffs.
The company also attempted to resolve the litigation through a controversial bankruptcy strategy commonly known as the “Texas Two-Step.”
Under that approach, a subsidiary created by J&J filed for bankruptcy with the aim of consolidating all talc-related claims into a single legal process.
However, courts rejected all three bankruptcy attempts, allowing the lawsuits to continue.
Following those setbacks, the company opted to pursue a comprehensive settlement with existing claimants.
What Happens Next?
The settlement proposal will now be circulated among eligible claimants.
If 95% approval is achieved, Johnson & Johnson could finally conclude one of the largest corporate product liability disputes in the United States.
If the required support is not obtained, the company is expected to continue defending thousands of lawsuits across US courts.
Frequently Asked Questions (FAQs)
1. How much is Johnson & Johnson paying to settle the baby powder lawsuits?
Johnson & Johnson has proposed a settlement worth approximately $5.5 billion.
2. How many lawsuits does the settlement cover?
The agreement covers around 76,000 ovarian cancer claims filed in the United States.
3. Has Johnson & Johnson admitted wrongdoing?
No. The company continues to deny that its talc-based products cause ovarian cancer or contain asbestos.
4. Is the settlement final?
No. It requires approval from 95% of eligible claimants before it becomes effective.
5. What were the allegations against Johnson & Johnson?
Plaintiffs alleged that prolonged use of talc-based baby powder caused ovarian cancer and that some products contained asbestos.
6. Why did Johnson & Johnson stop selling talc-based baby powder?
The company discontinued talc-based baby powder sales in the US in 2020 and introduced a cornstarch-based alternative.
7. What is the “Texas Two-Step”?
It is a legal strategy in which a company creates a subsidiary that files for bankruptcy to manage large numbers of lawsuits. Courts rejected Johnson & Johnson’s use of this approach.
8. Can future lawsuits still be filed?
Yes. The proposed settlement applies only to existing claims and does not block future legal actions.
9. When will settlement payments be made?
Johnson & Johnson expects to begin payments in 2027, with the remaining balance planned for 2028.
10. What happens if 95% of claimants do not approve the settlement?
If the required approval is not achieved, Johnson & Johnson could continue facing litigation in courts across the United States.
